StockData
Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock

RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)

Close on Oct 19, 2026Market cap $5.94MP/E –Yield –

Reviva Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Reviva Pharmaceuticals's price to book ratio was 0.4× on Oct 19, 2026, against 51.7× a year earlier. Over the last 4 years it ranged from 0.3× to 83.6×, with a median of 4.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.4×−5.7
2025Dec 31, 20256.1×−9.3
2024Apr 30, 202415.3×−46.3
2023Jul 31, 202361.6×+56.5
2022Dec 30, 20225.1×+3.8
2021Dec 31, 20211.2×−3.8
2020Dec 31, 20205.0×–

More Reviva Pharmaceuticals figures

See a number that looks wrong?